NASDAQ: LUMOLumos Pharma Inc Stock Ownership - Who owns Lumos Pharma?
Insider buying vs selling
Have Lumos Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John C. McKew | Chief Scientific Officer | 2024-04-03 | 2,214 | $2.78 | $6.14kSell |
| Richard J. Hawkins | Chief Executive Officer | 2024-04-01 | 1,522 | $2.84 | $4.32kSell |
| Richard J. Hawkins | Chief Executive Officer | 2024-04-01 | 4,500 | $2.84 | $12.78kBuy |
| Aaron Schuchart | Chief Business Officer | 2024-04-01 | 1,000 | $2.84 | $2.84kBuy |
| Bradley J. Powers | General Counsel | 2024-04-01 | 900 | $2.84 | $2.56kBuy |
| Lori D. Lawley | Chief Financial Officer | 2024-04-01 | 1,000 | $2.84 | $2.84kBuy |
| Lori D. Lawley | Chief Financial Officer | 2024-04-01 | 274 | $2.84 | $778.16Sell |
| Bradley J. Powers | General Counsel | 2024-04-01 | 342 | $2.84 | $971.28Sell |
| Pisit Duke Pitukcheewanont | Chief Medical Officer | 2024-04-01 | 6,000 | $2.84 | $17.04kBuy |
| John C. McKew | Chief Scientific Officer | 2024-04-01 | 1,036 | $2.84 | $2.94kSell |
LUMO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LUMO insiders and whales buy or sell their stock.
LUMO Shareholders
What type of owners hold Lumos Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Stine Seed Farm Inc | 96.92% | 7,857,732 | $21.96M | Insider |
| James E. Flynn | 9.68% | 784,568 | $2.19M | Insider |
| Richard J. Hawkins | 9.34% | 757,562 | $2.12M | Insider |
| Kevin M. Lalande | 9.02% | 731,522 | $2.04M | Insider |
| Wells Fargo Company | 5.14% | 417,051 | $1.17M | Institution |
| Goldman Sachs Group Inc | 5.02% | 406,611 | $1.14M | Institution |
| Blackstone Inc | 4.03% | 326,552 | $912.71k | Institution |
| Charles J. Link Jr. | 3.40% | 275,940 | $771.25k | Insider |
| Vanguard Group Inc | 3.01% | 244,082 | $682.21k | Institution |
| Renaissance Technologies LLC | 2.73% | 221,614 | $619.41k | Institution |
LUMO vs Biotech Stocks
Lumos Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.